Nano-silver is used in an increasing number of products. Some of the applications have resulted in the concern of governments and the public, since little is known about the potential risks of nano-silver. In this review, an inventory is made to identify knowledge gaps that have to be filled before risks for both man and the environment can be assessed as reliable as for ‘non-nanosized’ chemicals. It is hypothesized that the toxic effects of nano-silver are due to a combination of the specific properties of silver nanoparticles and the generation of ions from them. The main topic for future research is validation of our ‘0-hypothesis’ that toxic effects of nano-silver are proportional to the activity of free silver ions released by the nanoparticles. Furthermore, it must be determined whether – or to what extent – nano-silver particles will enter the body. The outcomes of these tests will determine the requirements for further toxicity testing.
Nanotoxicology
Volume 3, 2009 - Issue 2
3,878
Views
905
CrossRef citations to date
0
Altmetric
Original
Nano-silver – a review of available data and knowledge gaps in human and environmental risk assessment
Susan W.P. Wijnhoven Centre for Substances and Integrated Risk Assessment
,
Willie J.G.M. Peijnenburg Laboratory for Ecological Risk Assessment
,
Carla A. Herberts Centre for Biological Medicines and Medical Technology
,
Werner I. Hagens Centre for Substances and Integrated Risk Assessment
,
Agnes G. Oomen Centre for Substances and Integrated Risk Assessment
,
Evelyn H.W. Heugens Expertise Centre for Substances
,
Boris Roszek Centre for Biological Medicines and Medical Technology
,
Julia Bisschops Laboratory for Ecological Risk Assessment
,
Ilse Gosens Centre for Environmental Health Research
,
Dik Van De Meent Laboratory for Ecological Risk Assessment
,
Susan Dekkers Centre for Substances and Integrated Risk Assessment
,
Wim H. De Jong Laboratory for Health Protection Research, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
,
Maaike van Zijverden Expertise Centre for Substances
,
Adriënne J.A.M. Sips Centre for Substances and Integrated Risk Assessment
&
Robert E. Geertsma Centre for Biological Medicines and Medical TechnologyCorrespondenceRobert.Geertsma@rivm.nl
, MScshow allPages 109-138
Received 18 Jul 2008
Published online: 10 Jul 2009
Log in via your institution
Loading institutional login options...
Log in to Taylor & Francis Online
Restore content access
Restore content access for purchases made as guestPDF download + Online access
- 48 hours access to article PDF & online version
- Article PDF can be downloaded
- Article PDF can be printed
PDF download + Online access - Online
Checkout
Issue Purchase
- 30 days online access to complete issue
- Article PDFs can be downloaded
- Article PDFs can be printed
Issue Purchase - Online
Checkout
Purchase access via tokens
- Choose from packages of 10, 20, and 30 tokens
- Can use on articles across multiple libraries & subject collections
- Article PDFs can be downloaded & printed
From USD 450.00
per package
Learn more
per package
* Local tax will be added as applicable
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.